Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K-Ras4b Inhibitors.

Authors:
Jeuken S; Shkura O; Röger M; Brickau V; Choidas A and 6 more

Journal:
ChemMedChem

Publication Year: 2022

DOI:
10.1002/cmdc.202200392

PMCID:
PMC9826232

PMID:
35979853

Journal Information

Full Title: ChemMedChem

Abbreviation: ChemMedChem

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"The authors thank I. Polanz, S. Bettinger, and A. Siebert for measuring HRMS and routine NMR spectra as well as Stefanie Pütz for expert technical support. This work was supported by the European Regional Development Fund and the German province of North Rhine‐Westphalia (EFRE‐0800945, LS‐1‐2‐001a, EFRE‐0800947, LS‐1‐2‐001b, EFRE‐0800950, LS‐1‐2‐001c; RIST). Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025